Familial Hyperlipidemia Family Registry
1 other identifier
observational
11
1 country
1
Brief Summary
If a child from the Healthy Hearts and Minds education and screening program is found to have a genetic marker for familial hyperlipidemia (FH), immediate family members are offered genetic testing at no charge to identify those at high risk for cardiovascular disorders and those who carry the genetic markers. If identified early, the risk for cardiovascular disease can be greatly modified by early and proper treatment. The aim of the study is to gauge the impact of large-scale surveillance testing to identify those with the disorder and improve clinical care. This impact is both in disease prevention and in lessening the cost of long-term care from premature cardiovascular disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Feb 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 17, 2023
CompletedFirst Submitted
Initial submission to the registry
March 2, 2023
CompletedFirst Posted
Study publicly available on registry
April 14, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 29, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 29, 2025
CompletedResults Posted
Study results publicly available
December 19, 2025
CompletedDecember 19, 2025
December 1, 2025
2.3 years
March 2, 2023
July 30, 2025
December 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Familial Hypercholesterolemia (FH) Determination for Family Members of School Children With Elevated Cholesterol and Documented FH Variant
Individuals with elevated cholesterol group with familial hypercholesterolemia genotype.
The duration of participation in study is one day.
Eligibility Criteria
As above
You may qualify if:
- \* Primary family member of child from school screening program with documented familial hyperlipidemia (FH) variant
You may not qualify if:
- none
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Medical Center of the Rockies
Loveland, Colorado, 80528, United States
Results Point of Contact
- Title
- Gary J Luckasen, MD
- Organization
- UCHealth
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 4 Weeks
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 2, 2023
First Posted
April 14, 2023
Study Start
February 17, 2023
Primary Completion
May 29, 2025
Study Completion
May 29, 2025
Last Updated
December 19, 2025
Results First Posted
December 19, 2025
Record last verified: 2025-12